Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SURAKSHA DIAGNOSTIC LTD.

NSE : SURAKSHABSE : 544293ISIN CODE : INE877V01027Industry : Hospital & Healthcare ServicesHouse : Private

BSE278.4019.95 (+7.72 %)

PREV CLOSE ( ) 258.45

OPEN PRICE ( ) 268.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 18485

TODAY'S LOW / HIGH ( )256.95 282.00

52 WK LOW / HIGH ( )233.15 449

NSE278.1018.25 (+7.02 %)

PREV CLOSE( ) 259.85

OPEN PRICE ( ) 260.05

BID PRICE (QTY) 278.10 (110)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 262275

TODAY'S LOW / HIGH( ) 256.25 284.40

52 WK LOW / HIGH ( )231 449

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 15-03 2005

Management Info

Somnath Chatterjee - Chairman - Managing Director

Registered Office

Address Plot No D G-12/1, Action Area 1 D,Premises No 02-0327, New Town,Rajarhat,
Kolkata,
West Bengal-700156

Phone 033-66059750

Email investors@surakshanet.com

Website www.surakshanet.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

07Mar Suraksha Diagnostic informs about pres
In continuation to intimation letter dated 08 February 2025 and pursuant..

17Feb Suraksha Diagnostic informs about resi
In continuation to enclosed letter dated 16 January 2025 and in complian..

03Feb Suraksha Diagnostic informs about boar
Suraksha Diagnostic has informed that a meeting of the Board of Director..

26Dec Suraksha Diagnostic informs about clos
Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulati..

21Dec Suraksha Diagnostic informs about inve
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..

Financials

Rs. in Millions

	QTR Dec 24	ANNUAL
Net Profit	63.5700000000001
Gross Profit	84.1900000000001
Operating Profit	190.68
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Jupiter Life Line (BSE) 1550.10 (3.15%)	M.Cap ( in Cr)10163.39
Thyrocare Tech. (BSE) 699.85 (3.87%)	M.Cap ( in Cr)3708.75
Krishna Inst.Medi (BSE) 569.95 (3.66%)	M.Cap ( in Cr)22805.92
RainbowChildrenS Med (BSE) 1257.90 (1.14%)	M.Cap ( in Cr)12774.18
Global Health (BSE) 1178.80 (0.88%)	M.Cap ( in Cr)31661.08

Shareholding Pattern

	PROMOTERS	48.78%
	MUTUAL FUNDS/UTI	17.64%
	NON-INSTITUTION	15.39%
	FI/BANKS/INSURANCE	0.31%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

SURAKSHA DIAGNOSTIC LTD.